Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma

NCT06304636 is registered in ClinicalTrials.gov with Cartesian Therapeutics as lead sponsor.

NCT NCT06304636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06304636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma
Lead sponsor
Cartesian Therapeutics
Phase
Phase 1
Overall status
Terminated
Start date
June 19, 2024
Completion date
November 13, 2025
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory multiple myeloma, relapsed multiple myeloma